Literature DB >> 16407231

Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors.

Tim G Hales1, James I Dunlop, Tarek Z Deeb, Jane E Carland, Stephen P Kelley, Jeremy J Lambert, John A Peters.   

Abstract

Homomeric 5-hydroxytryptamine type 3A receptors (5-HT3ARs) have a single channel conductance (gamma) below the resolution of single channel recording (966 +/- 75 fS, estimated by variance analysis). By contrast, heteromeric 5-HT3A/B and nicotinic acetylcholine receptors (nAChRs) have picosiemen range gamma values. In this study, single channel recordings revealed that replacement of cytoplasmic membrane-associated (MA) helix arginine 432 (-4'), 436 (0'), and 440 (4') residues by 5-HT3B (-4'Gln, 0'Asp, and 4'Ala) residues increases gamma to 36.5 +/- 1.0 pS. The 0' residue makes the most substantial contribution to gamma of the 5-HT3AR. Replacement of 0'Arg by aspartate, glutamate (alpha7 nAChR subunit MA 0'), or glutamine (beta2 subunit MA 0') increases gamma to the resolvable range (>6 pS). By contrast, replacement of 0'Arg by phenylalanine (alpha4 subunit MA 0') reduced gamma to 416 +/- 107 fS. In reciprocal experiments with alpha4beta2 nAChRs (gamma = 31.3 +/- 0.8 pS), replacement of MA 0' residues by arginine in alpha4beta2(Q443R) and alpha4(F588R)beta2 reduced gamma slightly. By contrast, the gamma of double mutant alpha4(F588R)beta2(Q443R) was halved. The MA -4' and 4' residues also influenced gamma of 5-HT3ARs. Replacement of nAChR alpha4 or beta2 MA 4' residues by arginine made current density negligible. By contrast, replacement of both -4' residues by arginine produced functional nAChRs with substantially reduced gamma (11.4 +/- 0.5 pS). Homology models of the 5-HT3A and alpha4beta2 nAChRs against Torpedo nAChR revealed MA -4', 0', and 4' residues within five intracellular portals. This locus may be a common determinant of ion conduction throughout the Cys loop receptor family.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407231     DOI: 10.1074/jbc.M513222200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Authors:  M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

2.  Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function.

Authors:  Alexander Kuryatov; Wade Berrettini; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-09-29       Impact factor: 4.436

3.  Atomistic insights into human Cys-loop receptors by solution NMR.

Authors:  David D Mowrey; Monica N Kinde; Yan Xu; Pei Tang
Journal:  Biochim Biophys Acta       Date:  2014-03-28

Review 4.  Biophysics of P2X receptors.

Authors:  Terrance M Egan; Damien S K Samways; Zhiyuan Li
Journal:  Pflugers Arch       Date:  2006-05-13       Impact factor: 3.657

5.  Channel opening by anesthetics and GABA induces similar changes in the GABAA receptor M2 segment.

Authors:  Ayelet Rosen; Moez Bali; Jeffrey Horenstein; Myles H Akabas
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

6.  Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.

Authors:  V J Gee; S Kracun; S T Cooper; A J Gibb; N S Millar
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

Review 7.  Gating mechanisms in Cys-loop receptors.

Authors:  Jennie M E Cederholm; Peter R Schofield; Trevor M Lewis
Journal:  Eur Biophys J       Date:  2009-04-29       Impact factor: 1.733

8.  The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals.

Authors:  Daniel T Baptista-Hon; Tarek Z Deeb; Jeremy J Lambert; John A Peters; Tim G Hales
Journal:  J Biol Chem       Date:  2013-06-05       Impact factor: 5.157

9.  Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.

Authors:  Jon Lindstrom; Jie Luo; Alexander Kuryatov
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  Influence of the M3-M4 intracellular domain upon nicotinic acetylcholine receptor assembly, targeting and function.

Authors:  S Kracun; P C Harkness; A J Gibb; N S Millar
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.